Physician profile
Daniel P Jacobs
NPI 1629000385
$475.07
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.37 · 2020: $23.10 · 2021: $108 · 2022: $86.54 · 2023: $200 · 2024: $19.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $83.26 | 2023 | Esophyx |
| Janssen Biotech, INC. | $72.37 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.66 | 2019-2023 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.11 | 2021-2023 | Xifaxan |
| Abbvie INC. | $60.52 | 2021-2023 | |
| Boston Scientific Corporation | $40.22 | 2023 | Exalt Model D |
| Ferring Pharmaceuticals INC. | $32.29 | 2022 | |
| Axsome Therapeutics, INC. | $19.42 | 2024 | Sunosi |
| Redhill Biopharma INC. | $13.12 | 2023 | Aemcolo, Talicia, Movantik |
| Nestle Healthcare Nutrition INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.